Treats hypertension. ANDA 78212, held by Aurobindo Pharma. Benazepril Hydrochloride.
As of Nov 16, 2026, ANDA 78212 (Benazepril Hydrochloride), held by Aurobindo Pharma, was first approved by FDA on May 22, 2008, with 13 approved supplements and 0 published complete response letters.
Benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 22, 2008 | Original application | Approved | None posted |
| Benazepril Hydrochloride10MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride20MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Benazepril Hydrochloride40MG · tablet;oral | Benazepril Hydrochloride | Rx |
| Jan 13, 2026 | Supplement 28Manufacturing | Approved | None posted |
| Apr 2, 2019 | Supplement 17Labeling · Standard review | Approved | None posted |
| Sep 25, 2018 | Supplement 16Labeling · Standard review | Approved | None posted |
| Nov 12, 2015 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 28, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 28, 2015 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 28, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Nov 8, 2012 | Supplement 8Labeling | Approved | None posted |
| Nov 8, 2012 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 21, 2011 | Supplement 6Labeling | Approved | None posted |
| Dec 24, 2009 | Supplement 4Labeling | Approved | None posted |
| Jun 12, 2009 | Supplement 2Labeling | Approved | None posted |
| Aug 18, 2008 | Supplement 1Labeling | Approved | None posted |
| May 22, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters